Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study.
Blood Res
; 55(3): 139-145, 2020 Sep 30.
Article
in En
| MEDLINE
| ID: mdl-32792470
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Blood Res
Year:
2020
Document type:
Article
Affiliation country:
Italia